Rev Cardiovasc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesPioglitazone zita pioLiraglutide lirafitAlok malikSitagliptin sitazitRemogliflozin remoDapagliflozin zitaGlenmark pharmaceuticals limitedAmerican diabetes associationConsensus statement european society of cardiologyGlenmark pharmaceuticals ltdAmerican diabetes association professional practice committeeEuropean unionScientific document groupSteering committeeBiosimilars companies

What Does the COVID-Vaxxed Heart Require?

What Does the COVID-Vaxxed Heart Require?
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

United statesKhorasane janubiColleen huberMichal bednarek shutterstockOther vitamins for heart healthHealth viewpointsSigma aldrichOne two punch against spike proteinsTimes photoCellular mechanicsSomething controversialUniv medBrazilianj cardiovascCurr cardiolCardiovasc drugsRev cardiovasc

Anavex Life Sciences : Announces Issuance of New U S Patent ANAVEX®2-73 (blarcamesine)

Intellectual Property Portfolio for the Treatment of Hypertension Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing. | May 1, 2023

United statesChristopheru misslingAndrewj barwickiTrademark officeMichaelj fox foundation for parkinson researchCompany nasdaqResearch business developmentAnavex life sciences corpUs centers for diseaseIntellectual property portfolioLife sciencesUnited states patentChief executive officerHigh blood pressureDisease controlAnnual report

Development and Validation of a Nomogram for Estimation of Left Atrial

Development and Validation of a Nomogram for Estimation of Left Atrial Thrombus or Spontaneous Echo Contrast Risk in Non-Valvular Atrial Fibrillation Patients with Low to Borderline CHA2DS2-VASc Score

New yorkUnited statesJian junColl cardiolLifei panGeriatr cardiolEuropean association for cardioEuropean heart rhythm associationEuropean society of cardiologyTechnology ltdAmerican diabetes associationAmerican society of echocardiographyEuropean association of cardiovascular imagingRev cardiovascEuropean associationCardio thoracic surgery

Frontiers | Risk Factors for Postischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan

Background: The incidence of ischemic stroke has been increasing in the young population over the past 20 years. Poststroke epilepsy (PSE) is a common complication after stroke. However, few population-based studies with sufficient follow-up have investigated on factors associated with PSE in young stroke survivors. Accordingly, this study aimed to determine the long-term incidence and risk factors for PSE young adults. Methods: This cohort study was conducted using data from the Taiwan National Health Insurance Research Database (NHIRD) from 2002 to 2018. All patients aged between 19 and 44 years and diagnosed with ischemic stroke from 2002 to 2015 were retrospectively enrolled with a follow-up of at least three years. Multivariable Cox regression models were performed to identify predictors of PSE, including patients’ demographics, baseline conditions, stroke severity, etiologies, comorbidities, and unhealthy behaviors. Results: Among 6512 ischemic stroke patients, 402 cases (6.2%)

Ghana generalUnited statesT ai peiNew yorkCity ofUnited kingdomTrombolisi trombectomiaActa epileptologicaMar frajTatlisumakt youngRobels astroglialOffice of data scienceAmerican heart associationTaipei medical university joint institutional review boardTaipei medical universityHealth data analytics